SEC Form 4 · accession 0001104659-17-001233
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Guyer
Officer — Chief Executive Officer · Director
Period of report
Jan 4, 2017
Accepted (ET)
Jan 6, 2017 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 4, 2017 | M | 6,250 | — | A | 10,997 | D | |
| Common StockF2,F3 | Jan 5, 2017 | S | 3,785 | $4.96 | D | 7,212 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F4 | — | Jan 4, 2017 | M | 6,250 | D | — | Jan 3, 2026 | Common Stock | 6,250 | 18,750 | D |
Explanation of responses
- F1Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
- F2Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 4, 2017.
- F3These shares were disposed of in multiple transactions on January 5, 2017 at actual sales prices ranging from $4.90 to $5.04 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4On January 4, 2016, the reporting person was granted an award of 25,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan.